AMPIO PHARMACEUTICALS INC (AMPE) Forecast, Price Target & Analyst Ratings
NYSEARCA:AMPE • US03209T3077
0.62 USD
-0.09 (-12.91%)
Last: Apr 12, 2024, 08:04 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AMPIO PHARMACEUTICALS INC (AMPE).
Forecast Snapshot
Consensus Price Target
$2.04
+ 229.03% Upside
Next Earnings Forecast
Release DateMay 6, 2024
ChartMill Buy Consensus
43.33%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$2.04
Upside
+ 229.03%
From current price of $0.62 to mean target of $2.04, Based on 6 analyst forecasts
Low
$2.02
Median
$2.04
High
$2.10
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
6 analysts have analysed AMPE and the average price target is 2.04 USD. This implies a price increase of 229.03% is expected in the next year compared to the current price of 0.62.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
AMPE was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AMPE.
In the previous month the buy percentage consensus was at a similar level.
AMPE was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 6, 2024
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | ||||||||||
| EBITDA YoY % growth | -23.35M | -15.87M 32.03% | -14.35M 9.58% | -9.9M 31.01% | -17.31M -74.85% | -14.65M 15.37% | -19.48M -32.97% | -19.33M 0.77% | -9.396M 51.39% | |
| EBIT YoY % growth | -24.17M | -17.08M 29.33% | -15.56M 8.90% | -11.18M 28.15% | -18.58M -66.19% | -15.83M 14.80% | -20.57M -29.94% | -20.38M 0.92% | -9.518M 53.30% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 33.33% | -0.86 53.16% | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
AMPIO PHARMACEUTICALS INC / AMPE Forecast FAQ
What is the price target for AMPE stock?
6 analysts have analysed AMPE and the average price target is 2.04 USD. This implies a price increase of 229.03% is expected in the next year compared to the current price of 0.62.
What is the next earnings date for AMPE stock?
AMPIO PHARMACEUTICALS INC (AMPE) will report earnings on 2024-05-06, after the market close.
What is the consensus rating for AMPIO PHARMACEUTICALS INC (AMPE) stock?
The consensus rating for AMPIO PHARMACEUTICALS INC (AMPE) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.